Great West Life Assurance CO Biocryst Pharmaceuticals Inc Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 50,545 shares of BCRX stock, worth $367,462. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,545
Previous 17,374
190.92%
Holding current value
$367,462
Previous $108,000
255.56%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding BCRX
# of Institutions
280Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$148 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$145 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$86.3 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$66.1 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$64.3 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.35B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...